Inovalon to Participate at Annual Morgan Stanley and Bank of America Merrill Lynch Healthcare Conferences
September 06 2017 - 7:55AM
Inovalon (Nasdaq:INOV), a leading technology company providing
advanced, cloud-based platforms empowering a data-driven
transformation from volume-based to value-based models across the
healthcare ecosystem, today announced that Keith Dunleavy, M.D.,
Inovalon’s chief executive officer and chairman of the board, and
Christopher Greiner, Inovalon’s chief financial officer and chief
operating officer, will present at the upcoming Morgan Stanley 2017
Global Healthcare Unplugged Conference on September 11- 12, 2017,
at the Grand Hyatt Hotel in New York City.
The presentation will take place at 4:15 p.m.
(ET) on Monday, September 11, 2017. Investors may access a live
audio webcast of the presentation on the Investor Relations section
of Inovalon’s website at www.inovalon.com. An archived version will
remain posted for a limited time.
Additionally, Inovalon will be participating at
the Bank of America Merrill Lynch 2017 Healthcare Supply Channel
and HCIT Conference in Boston on September 26, 2017.
About Inovalon
Inovalon is a leading technology company
providing cloud-based platforms empowering a data-driven
transformation from volume-based to value-based models throughout
the healthcare industry. Through the Inovalon ONE™ Platform,
Inovalon brings to the marketplace a national-scale capability to
interconnect with the healthcare ecosystem on massive scale,
aggregate and analyze data in petabyte volumes to arrive at
sophisticated insights in real-time, drive impact wherever it is
analytically identified best to intervene, and intuitively
visualize data and information to inform business strategy and
execution. Leveraging its platform, unparalleled proprietary data
sets, and industry-leading subject matter expertise, Inovalon
enables the assessment and improvement of clinical and quality
outcomes and financial performance across the healthcare ecosystem.
From health plans and provider organizations, to pharmaceutical,
medical device, and diagnostics companies, Inovalon's unique
achievement of value is delivered through the effective progression
of “Turning Data into Insight, and Insight into Action®.” Providing
technology that supports nearly 500 healthcare organizations,
Inovalon's platforms are informed by data pertaining to more than
858,000 physicians, 377,000 clinical facilities, and more than 230
million Americans. For more information,
visit www.inovalon.com.
Contacts:
Kim Collins
Phone: 301-809-4000 x1473
kcollins@inovalon.com
George Price (Investors)
Phone: 301-809-4000 x1190
gprice@inovalon.com
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inovalon (NASDAQ:INOV)
Historical Stock Chart
From Apr 2023 to Apr 2024